HealthDay News — The Trump administration may cut off federal funding to hospitals that provide gender-related treatments to children and teens.

A 470% increase in OSA incidence over 15 years in Finland was linked to a 10,602% increase in remote care and a 2146% increase in nurse visits.

Pfizer and Moderna will now include more information on the risk of myocarditis on their COVID-19 vaccine labels.

The FDA has granted accelerated approval to Datroway for adults with previously-treated, locally advanced or metastatic EGFR-mutated NSCLC.

Phase 3 study results evaluating sotatercept-csrk in recently diagnosed adults with pulmonary arterial hypertension were announced.

A measles outbreak has been confirmed in Kentucky in connection with this year's nationwide spate of more than 1200 cases.

Nestle, Kraft Heinz, and General Mills have announced plans to remove all synthetic dyes from their products by 2027.

Sarilumab and tocilizumab are equally effective in reducing organ support duration and death in patients who are critically ill with COVID-19.

The new results helped boost Moderna’s stock by more than 4% in early trading June 30, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.

The United States will stop sending money to global pediatric vaccination initiative Gavi due to RFK Jr's concerns about vaccine safety.

Long-term exposure to particulate matter in patients with pulmonary arterial hypertension increases risk for lung transplantation or death.

The Supreme Court will not hear the case of an anti-vaccine activism group suing Meta Platforms for removing their content.